Variable radiographic and histologic presentations of amiodarone‐related interstitial lung disease and the importance of avoiding re‐exposure
Abstract Amiodarone is a commonly used antiarrhythmic agent but exhibits potential pulmonary toxicity. In this case series, we describe the clinical, radiographic, and histologic manifestations of three patients who developed interstitial lung disease (ILD) following amiodarone treatment for variabl...
Main Authors: | I‐Lin Tsai, Li‐Ting Huang, Yu‐Ting Yu, Chung‐Ta Lee, Tang‐Hsiu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-06-01
|
Series: | Respirology Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/rcr2.1165 |
Similar Items
-
Smoking history and underlying lung disease are associated with poor outcome in patients developing interstitial pneumonia during low-dose amiodarone therapy
by: Masatsugu Nozoe, MD, PhD, et al.
Published: (2013-02-01) -
Organizing pneumonia secondary to amiodarone treatment
by: João Gomes Carvalho, et al.
Published: (2022-09-01) -
Two sides of the coin: Amiodarone-induced lung toxicity – Case Report
by: Klaudiusz Garbacki, et al.
Published: (2022-08-01) -
Amiodarone-induced thyrotoxicosis: state of the art
by: Elena A. Lebedeva, et al.
Published: (2017-10-01) -
Acute myopathy secondary to amiodarone-induced thyrotoxicosis
by: Dave Duggan, et al.
Published: (2021-12-01)